1601 related articles for article (PubMed ID: 19546558)
1. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
2. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction.
Gaba RC; Riaz A; Lewandowski RJ; Ibrahim SM; Ryu RK; Sato KT; Omary RA; Salem R
J Vasc Interv Radiol; 2010 Aug; 21(8):1213-8. PubMed ID: 20598575
[TBL] [Abstract][Full Text] [Related]
3. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
[TBL] [Abstract][Full Text] [Related]
4. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
Salem R; Lewandowski RJ; Mulcahy MF; Riaz A; Ryu RK; Ibrahim S; Atassi B; Baker T; Gates V; Miller FH; Sato KT; Wang E; Gupta R; Benson AB; Newman SB; Omary RA; Abecassis M; Kulik L
Gastroenterology; 2010 Jan; 138(1):52-64. PubMed ID: 19766639
[TBL] [Abstract][Full Text] [Related]
5. Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.
Piana PM; Gonsalves CF; Sato T; Anne PR; McCann JW; Bar Ad V; Eschelman DJ; Parker L; Doyle LA; Brown DB
J Vasc Interv Radiol; 2011 Oct; 22(10):1373-9. PubMed ID: 21764600
[TBL] [Abstract][Full Text] [Related]
6. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
Atassi B; Bangash AK; Lewandowski RJ; Ibrahim S; Kulik L; Mulcahy MF; Murthy R; Ryu RK; Sato KT; Miller FH; Omary RA; Salem R
J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
[TBL] [Abstract][Full Text] [Related]
7. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
8. Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
Iñarrairaegui M; Thurston KG; Bilbao JI; D'Avola D; Rodriguez M; Arbizu J; Martinez-Cuesta A; Sangro B
J Vasc Interv Radiol; 2010 Aug; 21(8):1205-12. PubMed ID: 20598574
[TBL] [Abstract][Full Text] [Related]
9. Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.
Hanazaki K; Wakabayashi M; Sodeyama H; Kajikawa S; Amano J
Hepatogastroenterology; 1999; 46(30):3201-7. PubMed ID: 10626186
[TBL] [Abstract][Full Text] [Related]
10. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
[TBL] [Abstract][Full Text] [Related]
11. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.
Goin JE; Salem R; Carr BI; Dancey JE; Soulen MC; Geschwind JF; Goin K; Van Buskirk M; Thurston K
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):195-203. PubMed ID: 15713920
[TBL] [Abstract][Full Text] [Related]
12. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
13. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
Young JY; Rhee TK; Atassi B; Gates VL; Kulik L; Mulcahy MF; Larson AC; Ryu RK; Sato KT; Lewandowski RJ; Omary RA; Salem R
J Vasc Interv Radiol; 2007 Nov; 18(11):1375-82. PubMed ID: 18003987
[TBL] [Abstract][Full Text] [Related]
14. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
[TBL] [Abstract][Full Text] [Related]
16. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
[TBL] [Abstract][Full Text] [Related]
17. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors.
Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721
[TBL] [Abstract][Full Text] [Related]
18. Safety of repeated yttrium-90 radioembolization.
Lam MG; Louie JD; Iagaru AH; Goris ML; Sze DY
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1320-8. PubMed ID: 23354961
[TBL] [Abstract][Full Text] [Related]
19. Hepatic radioembolization with Yttrium-90 glass microspheres for treatment of primary liver cancer.
Cao X; He N; Sun J; Tan J; Zhang C; Yang J; Lu T; Li J
Chin Med J (Engl); 1999 May; 112(5):430-2. PubMed ID: 11593513
[TBL] [Abstract][Full Text] [Related]
20. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study.
Lewandowski RJ; Riaz A; Ryu RK; Mulcahy MF; Sato KT; Kulik LM; Gates VL; Baker T; Omary R; Salem R
J Vasc Interv Radiol; 2009 Dec; 20(12):1557-63. PubMed ID: 19854068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
